Impact of IL28B SNPs on therapeutic outcome and liver histology differs between hepatitis C virus genotypes.
Martin
M
Lagging
D054316:Biomarkers, Pharmacological; D056726:Genetic Association Studies; D016174:Hepacivirus / Q000187:drug effects / Q000235:genetics*; D006526:Hepatitis C / Q000188:drug therapy / Q000235:genetics / Q000821:virology; D019698:Hepatitis C, Chronic / Q000188:drug therapy / Q000235:genetics / Q000821:virology; D006801:Humans; D007372:Interferons / Q000378:metabolism; D007378:Interleukins / Q000235:genetics*; D008099:Liver / Q000187:drug effects / Q000473:pathology; D020641:Polymorphism, Single Nucleotide / Q000235:genetics; D016896:Treatment Outcome; D000095022:Interferon Lambda
D054316:Biomarkers, Pharmacological; D007372:Interferons; D007378:Interleukins; C000624353:interferon-lambda, human; D000095022:Interferon Lambda